Summary We have used the polymerase chain reaction to detect DNA sequences related to human papillomavirus type 16, by simultaneous priming with oligonucleotides from the E6 and LI/L2 open reading frames of the HPV16 genome. The HPV16-related sequence is present at low levels in normal oral tissue, in addition to biopsies and cell cultures from patients with benign and malignant disease. Ultimate analysis of the amplified sequences from the E6(120bp) and Ll/L2(173bp) regions of HPV16 was achieved by gel electrophoresis and comparative nucleotide sequencing. The oral carcinoma biopsies and tissue cultures contained DNA sequences which were identical to the E6 region of HPV16, but only rarely contained sequences closely related to the L1/L2 region. The PCR technology should permit the detection, identification and cloning of latent viruses from extremely small tissue biopsies.
Epidemiological studies have implied that an infectious agent may play a role in human oral cancer (reviewed by Scully et al., 1988) . A similar association has been noted between human cervical cancer and a specific infectious agent, namely human papillomavirus (HPV), in particular HPV type 16 (Howley, 1986) . In the United Kingdom, up to 80% of invasive cervical carcinomas probably contain HPV16 DNA (reviewed in Munoz et al., 1988) hence the implication of HPV16 as an aetiological agent in the disease. In oral lesions, HPV antigens and genes have been detected, principally in benign papillary lesions (Loning et al., 1985) , but also in carcinoma tissue (de Villiers et al., 1985) . Our own studies (Scully et al., 1987; Maitland et al., 1987a) indicated that a HPV, closely related to HPV16, was present as DNA at low levels in oral tissue types, ranging from histologically normal through benign leukoplakia to invasive carcinoma. If an aetiological role for HPV is proposed in oral cancer, it is necessary to determine the incidence of the virus in the affected population and to follow the interactions between HPV and the oral epithelium. Detailed epidemiological study, in contrast to simple screening, requires either large amounts of material or more sensitive techniques than those presently available, and it was with these aims in mind that the present work was undertaken.
First, to overcome the shortage of material, we have established keratinocyte cultures from oral squamous cell carcinoma tissue according to the method described by Rheinwald and Green (1975) and modified by Crane et al. (1986 and manuscript in preparation) . Secondly, we have developed the polymerase chain reaction (PCR), as originally described for the detection of point mutations in haemoglobinopathies and cellular oncogenes (Chehab et al., 1987; Saiki et al., 1986 Saiki et al., , 1988 Bos et al., 1987 (Shibata et al., 1988) . Using primers located in the E6 gene, which is preferentially retained and expressed in cervical carcinoma, and LI/L2 overlap region of HPV16 (Seedorf et al., 1985; Smotkin & Wettstein, 1986) In all cases the tissue extracted for DNA was adjacent to that from which frozen sections were cut for histology to minimise the effects of tissue heterogeneity on the extracted material.
Keratinocyte cultures were established from human oral squamous cell carcinoma tissue, and passaged without cloning as described by Crane et al. (1986) for rat oral squamous cell carcinoma tissue. DNA was extracted from healthy subconfluent cultures at various passages after initial establishment as a primary culture (see below). Cell cultures of CaSki were obtained from the ATCC.
Extraction and purification of DNA Nucleic acids (both DNA and RNA) were extracted according to a variation of the method of Chirgwin et al. (1979) as previously described (Maitland et al., 1987b ) from all of the tissue cultures and biopsies. Briefly, this involved homogenisation of the tissue in a detergent/guanidinium thiocyanate mixture, followed by ultracentrifugation for 16 h through a double cushion of caesium trifluoroacetate (Pharmacia) containing ethidium bromide. DNA formed a u.v. fluorescent band between the two cushions, whereas the RNA formed a solid pellet at the bottom of the centrifuge tube. This modification allows the maximum information to be obtained from a small (1 mm3) tissue biopsy.
Polymerase chain reaction PCR was carried out essentially according to the manufacturer's instructions for 30 cycles of denaturation (30 s at 910C), annealing (30s at 250C) and synthesis (5min at 550C) in a buffer containing 16.6mM ammonium sulphate, 67mM Tris.HCl pH 8.8, 6.7mM MgCl2, 10 mM mercaptoethanol, 6.7 M ethylene diamine tetraacetic acid (EDTA), 33 jM each of dATP, dCTP, dGTP and dTTP, 10% dimethylsulphoxide (DMSO), 0.5-1.0 g of human DNA target and 300ng of each primer DNA (the reaction will work with considerably lower primer concentrations) in a final volume of 50 p1. After the reaction mixture is prepared, and the first denaturation (7min at 91°C) completed, 1 unit of Taq DNA polymerase (Anglian Biotec) was added and the annealing, synthesis and denaturation were carried out for 10 cycles, when a second 1 unit of Taq polymerase was added. After 20 cycles a further I unit of the polymerase was added and the cycles continued up to 30. After this time half of the reaction products were removed, 1/10 volume of gel loading dye (0.25% bromophenol blue, 0.25% xylene cyanole, 25% Ficoll 400) was added to each and the samples were analysed on a polyacrylamide gel (12%) prepared in Tris/borate buffer (89mM Trisborate, 89mM boric acid, pH 7.8) by electrophoresis at 45mA for 60min. The final amplified oligonucleotide products were visualised by ethidium bromide stain (1 ug ml in Tris/borate buffer) and ultraviolet illumination.
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Nucleotide sequence analysis of PCR products The 298bp amplification product from the E6 gene primers 2 and 3 was purified from a 12% polyacrylamide gel by excision of the band, overnight elution in an excess of 0.1 xTE buffer at 37°C and centrifuge driven dialysis on a centricon 30 (Amicon) as described in Higuchi et al. (1988) . The 4041 product of this was freeze dried, resuspended in up to 8pl of ddH20 and approximately half of this (depending on the yield) was transcribed in vitro, using T7 RNA polymerase (Davanaloo et al., 1984 End labelled sequencing primer 2 Figure 1 Oligonucleotide primer sequences and locations on the HPV16 genome (adapted from Seedorf et al., 1985) (a) E6 gene primers, (b) LI/L2 overlap region primers, (c) T7 polymerase sequencing primer position in the E6 gene.
Results
Standard polymerase chain reaction on oral tissue DNA using HPV16 E6 gene primers One microgram of DNA from a number of different tissues and lesion types was subjected to the standard PCR at 55°C. We selected the E6 region of the HPV16 genome for amplification, and in particular a 120 bp fragment located close to the 3' terminus as shown in Figure la DNA sequence analysis of PCR products from the E6 region Preliminary comparative analysis of the PCR products from oral and cervical tissues was carried out with the restriction endonucleases shown in Figure la (data not shown) . Since the amounts of DNA obtained from a single PCR were close to the limits required for convincing restriction endonuclease analysis, we were anxious to confirm the identity of the DNA amplified by the E6 primers as HPV16 at the ultimate level, i.e. that of the sequence of the nucleotide bases in this region. Initial experiments, in which the 120bp E6 amplification products were directly sequenced with the sequenase system, produced disappointing results with material amplified from oral samples (whereas cervical samples gave correct sequences according to Seedorf et al. (1985) for both the E6 and L1/L2 genes). The lack of success with oral samples was attributed to the poor yields of PCR product and, to amplify these products further, we employed a third E6 primer, which was homologous to a 20 base sequence, 5' to the original primer 1. Attached to the HPV16 portion of this primer was a 28 base sequence, encoding the T7 phage RNA polymerase promoter (Davanaloo et al., 1984) . After purification of the 298 bp amplification product of this reaction, it was therefore possible to amplify the products by in vitro Reactions were performed on purified DNA from the sources indicated with the synthesis step carried out at 55°C. Analysis of the products was by 12% polyacrylamide gel electrophoresis. The position of molecular weight marker is shown arrowed on the left of the figure. transcription. Sequencing was accomplished with AMV reverse transcriptase from end-labelled primer 2 (Stoflet et al., 1988) . The results of a sequencing of one oral sample, and an HPV16 positive cervical carcinoma biopsy control are shown in Figure 3 . Over the entire legible range, the two sequences were identical (the locations of primer 1 and the restriction endonuclease sites from Figure 1 are also indicated). 
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Figure 3 Nucleotide sequence analysis of E6 amplification products from oral and cervical carcinoma DNA. Sequencing was carried out on the 298 bp product of a PCR with E6 primers 2 and 3 (see Figure lc) . The end-labelled sequencing primer was primer 2. The position of primer 1 in the determined sequence, and the restriction endonuclease cleavage sites from Figure la are also indicated.
Polymerase chain reaction on oral DNA samples using LJ/L2 primers To test whether the late regions of the HPV16 sequence were present in the oral tissues, we employed primers synthesised from the overlap region between the LI and L2 regions (Figure lb) . The results of the PCR with these primers are shown in Figure 4 . Positive controls with CaSki DNA and cloned HPV16 DNA were positive for both the early and late primers separately and on simultaneous priming with all four oligonucleotides, to give the expected 120 and 173 bp amplification products respectively. Similar results were obtained with other cervical tumour DNA samples which contained considerably lower amounts (one to two genomes per cell) of HPV 16 DNA per cell (data not shown). In contrast, DNA from the oral tissues and cultures was positive only for the E6 diagnostic fragment, even under the less stringent reaction conditions, with the possible exception of culture H157(17) and SCC biopsy 1, which were weakly positive with the L1/L2 primers. In our experience, this implies an extremely low level of late genes, perhaps in a small number of the cells in the biopsy or culture, whereas early genes are present in the majority of the cells. In some of the oral samples, a number of low molecular weight bands (<80bp) were detected. However, these bands failed to react with a HPV16 DNA probe (data not shown). Multiple low molecular weight bands of this nature were often observed, particularly when several sets of primers were employed simultaneously, but a positive reaction was only scored when the amplification product predicted from the published DNA sequence was observed. 
Figure 4 Simultaneous polymerase chain ractions using primers for E6 and LI/L2 regions on oral carcinoma culture and biopsy DNA. Analysis of the PCR products was carried out on a 12%
polyacrylamide gel. Predicted sizes of the amplification products are shown arrowed on the left.
Discussion
Our previous results (Scully et al., 1987; Maitland et al., 1987a) indicated that papillomavirus DNA, closely related to, but not identical to that from the potentially oncogenic cervical HPV type 16, could be detected in nucleic acid preparations from a number of oral lesions, including cancers. To further explore the nature of the oral variant of HPV16, we produced cultures from the tumour tissues, but even in these uncloned keratinocyte cultures, detection of HPV DNA was technically difficult. The weak signals could have been due to nucleotide base sequence differences between the cervical HPV16, which we used as a hybridisation probe, and the related oral virus. Equally, the positive results could have resulted from cross-hybridisation between human DNA sequences and the viral probe. By employing the PCR we were able to produce unequivocally positive results, in almost 50% of oral carcinomas tested, even with the smallest oral tissue biopsies. This value is entirely in agreement with our earlier results (Maitland et al., 1987a ). The design of oligonucleotide primers for the PCR technique used in this study was based on our previous results (Maitland et al., 1987a) . The E6 gene sequences are consistently retained in both cervical and oral carcinomas (Baker et al., 1987; Smotkin & Wettstein, 1986 ; N. Maitland, unpublished data), whereas the late genes (LI/L2) are often deleted in cervical carcinomas when the HPV16 genome is integrated into the cell genome. In addition, only a very small proportion of the oral samples in our previous study contained detectable HPV16 late genes.
Using this combination of oligonucleotide primers the results again bore out those of our previous work, in that early genes were readily detected, whereas the late genes were freqently absent in oral tissues. Confirmation of the identity of the viral DNA present in the oral tissues was achieved by direct nucleotide sequencing of a portion of the E6 gene.
Employing a third primer from this gene and in vitro transcription from the T7 phage RNA polymerase promoter, sufficient HPV template for nucleotide sequencing was produced. The sequencing indicated that the oral and cervical HPV16 E6 genes were, as predicted from the restriction endonuclease digestions, identical over the 120bp amplified in the initial experiments, including the primer 1 sequence. It is perhaps significant in view of the essential role of E6 gene expression in tumours that the E6 genes from a total of nine oral and nine cervical HPV16 positive samples sequenced to date show no sequence variations (manuscript in preparation).
Unfortunately, we are still unable to determine, on the basis of either the Southern blotting or the PCR results, whether the frequently negative result with the late region primers is due to lack of these sequences, or to gross sequence divergence, which would make both annealing of high complexity probes in Southern blotting or low complexity oligonucleotide primers for the PCR unlikely. The detection of multiple low molecular weight bands in the simultaneous E6 and LI/L2 priming (Figure 4 ) experiments probably represents self-priming of the cellular DNA, but could equally be the result of viral genome rearrangements. The failure of these 'ladders' to hybridise to an HPV 16 probe argues in favour of the former explanation, however. If the late regions were completely absent, then the oral (sequences' would not represent a viable virus.
The resolution of these two possibilities requires cloning of the HPV16 homologous sequences from the oral cultures, which will provide the required amounts of DNA. Using the amplified sequence for the E6 region as an homologous hybridisation probe, we are now able to clone the entire HPV16-related sequence and to determine its role in oral diseases, including cancer.
The use of the PCR has overcome some of the extreme difficulties experienced in the analysis, at the molecular level, of extremely small tissue samples and heterogeneous primary cell cultures. The technique should also assist in epidemiological studies of virus incidence, without the compromises in sensitivity which are often necessary in the handling of large sample numbers.
